Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bonnie J Howell

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Journal of Virology|July 20, 2022
Detecting Sources of Immune Activation and Viral Rebound in HIV InfectionStephen W Wietgrefe, Lijie Duan, Jodi Anderson, et al.
HIV Research & Clinical Practice|March 29, 2022
"We are looking at the future right now": community acceptability of a home-based viral load test device in the context of HIV cure-related research with analytical treatment interruptions in the United StatesKarine Dubé, John Kanazawa, Christopher Roebuck, et al.
HIV Research & Clinical Practice|August 15, 2022
Participant experiences using novel home-based blood collection device for viral load testing in HIV cure trials with analytical treatment interruptionsKarine Dubé, Harsh Agarwal, William B Carter, et al.
Journal of Clinical Microbiology|November 18, 2025
Comparison of manual and automated ultrasensitive assays for residual HIV-1 in plasma from individuals on suppressive antiretroviral therapySonia Bakkour Coco, Mars Stone, Xutao Deng, et al.
Bioconjugate Chemistry|January 14, 2014
Improving the in vivo therapeutic index of siRNA polymer conjugates through increasing pH responsivenessErin N Guidry, Julie Farand, Arash Soheili, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2022
Impact of Tamoxifen on Vorinostat-Induced Human Immunodeficiency Virus Expression in Women on Antiretroviral Therapy: AIDS Clinical Trials Group A5366, The MOXIE TrialEileen P Scully, Evgenia Aga, Athe Tsibris, et al.
International Journal of Pharmaceutics|March 11, 2014
An in vivo evaluation of amphiphilic, biodegradable peptide copolymers as siRNA delivery agentsStephanie E Barrett, Marc T Abrams, Rob Burke, et al.
AIDS (London, England)|September 29, 2021
Neurotoxicity with high-dose disulfiram and vorinostat used for HIV latency reversalJames H McMahon, Vanessa A Evans, Jillian S Y Lau, et al.
Bioengineering & Translational Medicine|September 11, 2023
A high-throughput microfluidic mechanoporation platform to enable intracellular delivery of cyclic peptides in cell-based assaysStephen H Kasper, Stephanie Otten, Brian Squadroni, et al.
Journal of Personalized Medicine|February 25, 2022
Preliminary Acceptability of a Home-Based Peripheral Blood Collection Device for Viral Load Testing in the Context of Analytical Treatment Interruptions in HIV Cure Trials: Results from a Nationwide Survey in the United StatesKarine Dubé, Shadi Eskaf, Elizabeth Hastie, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Journal of Virology|July 20, 2022
Detecting Sources of Immune Activation and Viral Rebound in HIV InfectionStephen W Wietgrefe, Lijie Duan, Jodi Anderson, et al.
HIV Research & Clinical Practice|March 29, 2022
"We are looking at the future right now": community acceptability of a home-based viral load test device in the context of HIV cure-related research with analytical treatment interruptions in the United StatesKarine Dubé, John Kanazawa, Christopher Roebuck, et al.
HIV Research & Clinical Practice|August 15, 2022
Participant experiences using novel home-based blood collection device for viral load testing in HIV cure trials with analytical treatment interruptionsKarine Dubé, Harsh Agarwal, William B Carter, et al.
Journal of Clinical Microbiology|November 18, 2025
Comparison of manual and automated ultrasensitive assays for residual HIV-1 in plasma from individuals on suppressive antiretroviral therapySonia Bakkour Coco, Mars Stone, Xutao Deng, et al.
Bioconjugate Chemistry|January 14, 2014
Improving the in vivo therapeutic index of siRNA polymer conjugates through increasing pH responsivenessErin N Guidry, Julie Farand, Arash Soheili, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 17, 2022
Impact of Tamoxifen on Vorinostat-Induced Human Immunodeficiency Virus Expression in Women on Antiretroviral Therapy: AIDS Clinical Trials Group A5366, The MOXIE TrialEileen P Scully, Evgenia Aga, Athe Tsibris, et al.
International Journal of Pharmaceutics|March 11, 2014
An in vivo evaluation of amphiphilic, biodegradable peptide copolymers as siRNA delivery agentsStephanie E Barrett, Marc T Abrams, Rob Burke, et al.
AIDS (London, England)|September 29, 2021
Neurotoxicity with high-dose disulfiram and vorinostat used for HIV latency reversalJames H McMahon, Vanessa A Evans, Jillian S Y Lau, et al.
Bioengineering & Translational Medicine|September 11, 2023
A high-throughput microfluidic mechanoporation platform to enable intracellular delivery of cyclic peptides in cell-based assaysStephen H Kasper, Stephanie Otten, Brian Squadroni, et al.
Journal of Personalized Medicine|February 25, 2022
Preliminary Acceptability of a Home-Based Peripheral Blood Collection Device for Viral Load Testing in the Context of Analytical Treatment Interruptions in HIV Cure Trials: Results from a Nationwide Survey in the United StatesKarine Dubé, Shadi Eskaf, Elizabeth Hastie, et al.
Pageof 6